BIOVECTRA Conducting “Targeted Workforce Adjustments”, Dozens of Jobs Affected
What’s Happening at BIOVECTRA?
BIOVECTRA is reportedly conducting “targeted workforce adjustments” in 2026.
Agilent Technologies, who acquired the PEI-based pharmaceutical company in 2024, told CBC News that “less than 45 employees” are affected.
Multiple staffers have reached out to Samfiru Tumarkin LLP about their severance offers.
More BIOVECTRA Layoff Coverage
For a full overview of layoffs at BIOVECTRA and the rights that non-unionized employees in Canada have in this situation, see our BIOVECTRA Layoffs & Severance Guide.
Disclaimer: The materials above are provided as general information about the rights of non-unionized employees in Canada. It is not specific to any one company and SHOULD NOT be read as suggesting any improper conduct on the part of any specific employer, or a relationship between Samfiru Tumarkin LLP and a specific employer.